Lumera Announces New Podcast Interviews with Kimberly D.C. Trapp and Dr. Craig Beeson; Next in 2007 Lumera Experts Series

Lumera Corporation (NASDAQ:LMRA), a leader in the emerging field of nanotechnology, announced today the release of its newest podcast interviews with Kimberly D.C. Trapp, Industry Liaison Officer at Lehigh University Center for Optical Technologies as well as an interview with Dr. Craig Beeson, Associate Professor of the Department of Pharmaceutical Sciences at the Medical University of South Carolina (MUSC). Ms. Trapp, who is also a member of Lumera’s Board of Directors, has twenty-three years experience in the optoelectronics and telecommunications industries having served, most recently, as Marketing Operations Director at Agere Systems. She held prior marketing and technical management positions at Lucent Technologies and AT&T Bell Laboratories. "What is very exciting about Lumera is the strategy and the view Lumera has had for some time about nanotechnology and nano-photonics. Lumera has already made major strides in these areas with the capabilities of their polymer work as well as some of the other applications of their technology,” said Ms. Trapp. "Nano-engineering, nano-photonics and nanotechnology have been synonymous with Lumera since the beginning as it is clearly part of their strategy and forward looking view of the marketplace.” Dr. Beeson, whose research combines biophysical and organic chemistry with cell biology, is currently working with Lumera to develop next generation toxicology methods. Earlier this year, Lumera announced that it had extended its collaboration agreement with MUSC to develop an antibody array that will measure the levels and modifications of patient mitochondrial proteins. "Technological advances such as the Lumera Proteomic Processor™ allow us to gather more detailed qualitative information that is specific in helping us understand the structure of molecules,” said Dr. Beeson. "This is essentially where the cutting edge research is now in terms of really understanding biological systems. The only way to understand how they work is by using technologies that allow you to take apart all the tiny little parts.” "We are pleased to be associated with leading experts in the fields of electroptics and nanotechnology,” commented Lumera Chief Executive Officer Tom Mino. "Both Ms. Trapp and Dr. Beeson have not only made significant contributions to our business in helping us develop cutting-edge market technologies, but also in advancing research and understanding in each of their respective industries.” Earlier this year, Lumera announced the 2007 Lumera Experts Podcast Series featuring interviews with industry leaders who are familiar with Lumera’s technology and are experts in nanotechnology, bio-arrays, drug discovery, electro-optics, and wireless technologies. Podcast interviews by the following individuals have all been previously featured as part of the series and are currently available to download on Lumera’s website: Dr. Charlie Campbell, a Professor of Chemistry and founding co-director of the Center of Nanotechnology at the University of Washington as well as a member of Lumera’s Scientific Advisory Board Dr. Niro Ramachandran, a research associate at the Harvard Institute of Proteomics led by Dr. Josh LaBaer Dr. Larry Dalton, a Professor of Chemistry and Electrical engineering at the University of Washington and Nobel Prize Nominee Dr. Joseph Vallner, recently President and CEO of Capnia Tom Mino, CEO of Lumera Dr. Sam Gambhir, professor of radiology and bioengineering, Director of the Molecular Imaging Program and head of the nuclear medicine division at Stanford University Dr. Jonathan Wells, Principal Partner at AJIS LLC, a broadband wireless technology consultancy and recently Director of Product Management and International Regulatory Affairs for GigaBeamhave About Lumera Lumera is a leader in the emerging field of nanotechnology. The company designs proprietary molecular structures and polymer compounds for the bioscience and communications/computing industries, both of which represent large market opportunities. The company also has developed proprietary processes for fabricating such devices. For more information, please visit www.lumera.com. Certain statements contained in this release are forward-looking statements that involve a number of risks and uncertainties. Factors that could cause actual results to differ materially from those projected in the company's forward-looking statements include the following: market acceptance of our technologies and products; our ability to obtain financing; our financial and technical resources relative to those of our competitors; our ability to keep up with rapid technological change; government regulation of our technologies; our ability to enforce our intellectual property rights and protect our proprietary technologies; the ability to obtain additional contract awards and to develop partnership opportunities; the timing of commercial product launches; the ability to achieve key technical milestones in key products; and other risk factors identified from time to time in the company's SEC reports, including its Annual Report on Form 10-K, and its Quarterly Reports on Form 10-Q.